Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge

Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced malignancies, including non-small cell lung cancer (NSCLC). These agents have improved clinical outcomes and have become quite an attractive alternative alone or combined with other treatments. Although ICIs are tolera...

Full description

Bibliographic Details
Main Authors: Raju Vaddepally, Rajiv Doddamani, Soujanya Sodavarapu, Narasa Raju Madam, Rujuta Katkar, Anupama P. Kutadi, Nibu Mathew, Rohan Garje, Abhinav B. Chandra
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Biomedicines
Subjects:
NSCLC
immunotherapy
irAEs
rechallenge
multisystem irAEs
Online Access:https://www.mdpi.com/2227-9059/10/4/790

Internet

https://www.mdpi.com/2227-9059/10/4/790

Similar Items